Reduction of Suicidality during Clozapine Treatment of Neuroleptic-Resistant Schizophrenia: Impact on Risk-Benefit Assessment

Herbert Y. Meltzer*, Ghadeer Okayli

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

442 Scopus citations

Fingerprint Dive into the research topics of 'Reduction of Suicidality during Clozapine Treatment of Neuroleptic-Resistant Schizophrenia: Impact on Risk-Benefit Assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences